About Roger S Gammon
Dr. Roger Gammon is originally from Drexel, Missouri. He received his Bachelor’s and Medical Degree from the University of Missouri-Kansas City School of Medicine. Dr. Gammon began eight years of postgraduate training with an Internal Medicine residency at Parkland Memorial Hospital in Dallas where he was chosen Chief Resident. This was followed by a fellowship in Interventional Cardiology at Duke University Medical Center. Dr. Gammon enjoys being on the cutting edge of research and technology, while applying it in an individualized and personal manner to his patients. Dr. Gammon is Director of Research at Austin Heart. In that capacity he has been Principal Investigator on over 100 studies with a particular interest in stem cell studies. Dr. Gammon also enjoys teaching and has given hundreds of invited lectures and published over 50 articles or textbook chapters. He is triple board certified in Internal Medicine, Cardiology, and Interventional Cardiology. He began practice in Austin, Texas in 1992.
Awards & Special Recognition:
- Super Doctors® - 2007, 2008, 2010, 2011, 2012, 2013, 2014, 2015, 2016
- Austin Business Journal Health Care Hero – Stem Cell Research
- National Research Service Award
- Eli Lilly Clinical Scholar
- Who’s Who in Health and Medical Services
- Visiting Chief Resident, Massachusetts General Hospital, Harvard
- Visiting Clinical Clerkship, Yale University Medical School
Invasive and Interventional Cardiology; Arterial and Venous Intervention
Family, travel, hunting, fishing, and outdoors
- Travis County Medical Society
- Texans for Stem Cell Research, Medical Advisory Board
- Horizons International Peripheral Group
- Duke University Consortium for Clinical Research
- Associate Medical Director, Austin Heart, PA (1998-present)
- Chief of Cardiology, Seton Medical Center (1998-2000)
- Director of Research, Austin Heart, PA (1994-present)
- Quality Assurance Committee, Cardiology Division, Seton Medical Center (1994-1997)
- Director, Cardiac Cath Lab Steering Committee, Seton Medical Center (1994-1997)
- Board of Directors, American Heart Association, Austin Chapter (1993)
- Physician Advisory Council, Cardiac Catheterization Lab, Central TX Heart Institute (1993)
- Presenter, American Heart Association National Convention (1990)
- Presenter, American College of Cardiology National Convention (1990)
- Clinical Competence Committee, Parkland Memorial Hospital (1987-1988)
- Quality Assurance Committee, Parkland Memorial Hospital (1987-1988)
- Medical Advisory Committee, Parkland Memorial Hospital (1987-1988)
- Quality Assurance Committee, Dallas Veterans Administration Hospital (1987-1988)
- Pharmacy and Therapeutics Committee, Dallas Veterans Administrations Hospital (1987-1988)
- Instructor in Physical Examination and Diagnosis, Duke University Physician Assistant Program (1987-1988)
- Instructor in Physical Examination and Diagnosis, University of Texas Southwestern Physician Assistant Program (1985)
- Clerkship, Cardiology, University of Texas Health Science Center (1983)
- University Scholar, University of Missouri, Kansas City, Missouri (1979-1981)
- Curator Scholar, University of Missouri-Kansas City (1978)
- Valedictorian, Drexel High School, Resolution of Recognition Outstanding Achievement, Missouri Senate (1978)
- Reisz GR, Gammon RS. Toxic pneumonitis from mixing household cleaners. CHEST 1986;89:49-52.
- McBride W, Jackman JD Jr, Gammon RS, Willerson JT. High-output cardiac failure in patients with multiple myeloma. N Engl J Med 1988;319:1651-1653.
- Chapman GD, Gammon RS, Bauman RP, Howell S, Clark H, Mikat E, Palmos L, Buller CE, Stack RS. A bioabsorbable stent: Initial experimental results. Circulation 1990;82(Suppl III):III-72.
- Gammon RS, Chapman GD, Bauman RP, Muhlstein JB, Overman AB, Desper JS, MacGregor DC, DeCoriolis PE, Stack RS. The Cordis balloon-expandable stent: Implantation features and long-term follow-up in an animal model. Circulation 1990:82(suppl II):III-541.
- Chapman GD, Gammon RS, Bauman RP, Stack RS. Intravascular stents: A review. Trends in Cardiovascular Medicine 1991;1:127-131.
- Gammon RS, Chapman GD, Agrawal GM, Bauman RP, Philips HR, Clark HG, Stack RS. Mechanical features of the Duke biodegradable stent. J Am Coll Cardiol 1991;17:235A.
- Chapman GD, Lim CS, Swain JL, Gammon RS, Bauman RP, Stack RS. In viro cardiovascular gene transfer via interventional technique: Initial experimental results. J Am Coll Cardiol 1991;1725:A.
- Gammon RS, Chapman GD, Bauman RP, Stack RS. Bioabsorbable endovascular stent prostheses. In Sigwart U (ed.), Cardiac Stenting, Springer-Verlag, New York.
- Chapman GD, Lim CS, Gammon RS, Culp SC, Desper JS, Bauman RP, Swain JL, Stack RS. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circulation Research.
- Gammon RS, Sketch MH Jr, Stack RS. Transluminal Extraction Endarterectomy. In Serruys PW, Strauss BH, King III SB (ed.) Restenosis: After Intervention with new mechanical devices. Kluwer Academic Publishers, Boston, MA pp.259-272, 1992.
- Zidar JP, Gammon RS, Chapman GD, Culp SC, Brott BC, Clark H, Bauman RP, Waller BF, Phillip HR, Stack RS. Short and long-term vascular tissue response to the Duke bioabsorbable stent. J Am Coll Cardiol, 1993.
- Zidar JP, Virmani R, Culp SC, Bauman RP, Wells HA, Gammon RS, Chapman GD, Jackman JD, Phillips HR, Stack RS. Quantitative histopathologic analysis of the vascular response to heparin coating of the Cordis stent. J Am Coll Cardiol, 1993.
- Kruse KR, Greenberg CS, Tangusay JF, Gammon RS, Muhlstein JB, Krucoff MW, Matar FA, Morrison LA, Sawchak SR, Berkowitz SD, Philips HR, Stack RS, Califf RM, Zidar JP. Thrombin and fibrin activity in patients treated with Enoxaparin, Ticlopidine and aspirin versus the conventional Coumadin regimen after elective stenting: The ENTICES Trial. J Am Coll Cardiol, 1996; Vol 27, No. 2:p.334A.
- Goolsby JP, Gammon RS, Pederson RW, et al. Coronary Stenting: The Austin Heart Experience. Travis County Medical Society Journal, May/June 1997.
- Gammon, RS,. Ducote, V., Kalmaz, D., Hagan, K., Cheema, A., and Rodgers, G. Impact of Ticlopidine on Bleeding Events During Coronary Artery Bypass (CAB). The American Journal of Cardiology, TCT Abstracts, October 1998.
- Rosenfield K, Jaff MR, White CJ, Rocha-Singh K, Mena-Hurtado, Metzger C, Brodman M, Pilger E, Zeller T, Krishnan P, Gammon R for the LEVANT 2 Investigators. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. New England Journal of Medicine 2015; 373: 145-153.
University of Missouri-Kansas City School of Medicine, Kansas City, MO
Parkland Medical Center, Dallas, TX
Duke University Medical Center, Durham, NC
Certifications & Memberships
Internal Medicine, Cardiovascular Disease, Interventional Cardiology
Peripheral Vascular Interventions
3801 N. Lamar, Suite 300
Austin, TX 78756
Phone: (512) 206-3600
Fax: (512) 206-3604
8:00am - 5:00pm